** Australian healthcare stocks .AXHJ slip 1.2% to a one-week low, extending declines from previous session
** Vaccine maker CSL CSL.AX down 1.8%; biopharma Telix TLX.AX drops 3.3%
** US President Trump signs executive order aiming to reduce approval time for local pharma plants to encourage domestic manufacturing; plans pharma tariffs in next two weeks
** Australian healthcare firms largely depend on exports to the U.S. and are hurt by a strong Australian dollar, which has hit a new five-month peak. AUD/
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。